Kallisio featured in the LSI 2025 Emerging Innovators Report.

BALTIMORE, MD (December 22, 2025) — Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with Stanford Health Care to support the clinical implementation of its FDA-cleared Stentra system for use in head and neck cancer radiation therapy. Stentra is a patient-specific intraoral positioning system designed to support consistent immobilization during external […]

Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Nullam quis risus eget urna mollis ornare vel. Nulla vitae elit libero, a pharetra augue. Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Sed posuere consectetur est at lobortis. Cras mattis consectetur purus sit amet fermentum. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh. Cras mattis consectetur purus.

Kallisio has achieved a major milestone in its mission to transform cancer care with the recent FDA 510(k) clearance of Stentra™, its patient-specific 3D-printed intraoral immobilization and positioning device designed for radiotherapy in head and neck cancers. The device, tailored for each patient through digital dental impressions, aims to optimize the positioning of anatomical structures […]